posted on 2015-06-25, 00:00authored byGirish Chandra, Yang Won Moon, Yoonji Lee, Ji Yong Jang, Jayoung Song, Akshata Nayak, Kawon Oh, Varughese A. Mulamoottil, Pramod K. Sahu, Gyudong Kim, Tong-Shin Chang, Minsoo Noh, Sang Kook Lee, Sun Choi, Lak Shin Jeong
On the basis of the potent inhibitory
activity of neplanocin A
(1) against S-adenosylhomocysteine (AdoHcy)
hydrolase, we analyzed the comprehensive structure–activity
relationships by modifying the adenine and carbasugar moiety of 1 to find the pharmacophore in the active site of the enzyme.
The introduction of 7-deazaadenine instead of adenine eliminated the
inhibitory activity against the AdoHcy hydrolase, while 3-deazaadenine
maintained the inhibitory activity of the enzyme, indicating that
N-7 is essential for its role as a hydrogen bonding acceptor. The
substitution of hydrogen at the 6′-position with fluorine increased
the inhibitory activity of the enzyme. The one-carbon homologation
at the 5′-position generally decreased the inhibitory activity
of the enzyme, indicating that steric repulsion exists. A molecular
docking study also supported these experimental data. In this study,
6′-fluoroneplanocin A (2) was the most potent
inhibitor of AdoHcy hydrolase (IC50 = 0.24 μM). It
showed a potent anti-VSV activity (EC50 = 0.43 μM)
and potent anticancer activity in all the human tumor cell lines tested.